0001213900-24-029808.txt : 20240403
0001213900-24-029808.hdr.sgml : 20240403
20240403160152
ACCESSION NUMBER: 0001213900-24-029808
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20240403
DATE AS OF CHANGE: 20240403
EFFECTIVENESS DATE: 20240403
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: NLS Pharmaceutics Ltd.
CENTRAL INDEX KEY: 0001783036
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: V8
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-509559
FILM NUMBER: 24818602
BUSINESS ADDRESS:
STREET 1: THE CIRCLE 6
STREET 2: 8058
CITY: ZURICH
STATE: V8
ZIP: CH-6370
BUSINESS PHONE: 41-41-618-80-00
MAIL ADDRESS:
STREET 1: THE CIRCLE 6
STREET 2: 8058
CITY: ZURICH
STATE: V8
ZIP: CH-6370
D
1
primary_doc.xml
X0708
D
LIVE
0001783036
NLS Pharmaceutics Ltd.
THE CIRCLE 6
ZURICH
V8
SWITZERLAND
CH-8058
41.44.512.2150
SWITZERLAND
None
None
Other
Limited Company
true
Alexander
Zwyer
The Circle 6
Zurich
V8
SWITZERLAND
CH-8058
Executive Officer
Director
Chief Executive Officer
Ronald
Hafner
The Circle 6
Zurich
V8
SWITZERLAND
CH-8058
Director
George
Apostol
The Circle 6
Zurich
V8
SWITZERLAND
CH-8058
Executive Officer
Chief Medical Officer
Elena
Thyen-Pighin
The Circle 6
Zurich
V8
SWITZERLAND
CH-8058
Executive Officer
Chief Financial Officer
Gian-Marco
Rinaldi
The Circle 6
Zurich
V8
SWITZERLAND
CH-8058
Director
Audrey
Greenberg
The Circle 6
Zurich
V8
SWITZERLAND
CH-8058
Director
Anthony
Walsh
The Circle 6
Zurich
V8
SWITZERLAND
CH-8058
Director
Claudio
L.A.
Bassetti
The Circle 6
Zurich
V8
SWITZERLAND
CH-8058
Director
Florence
Allouche
Aknin
The Circle 6
Zurich
V8
SWITZERLAND
CH-8058
Director
Eric
Konofal
The Circle 6
Zurich
V8
SWITZERLAND
CH-8058
Executive Officer
Chief Scientific Officer
Pharmaceuticals
Decline to Disclose
- 06b
false
2024-03-20
false
true
true
true
false
0
H.C. Wainwright & Co., LLC
375
None
None
430 PARK AVE
3RD FLOOR
NEW YORK
NY
NEW YORK
10022
NY
NEW YORK
false
1750000
1750000
0
Represents total gross proceeds received by the company in connection with a concurrent registered direct offering of common shares and concurrent private placement of warrants to purchase common shares.
false
2
140000
0
H.C. Wainwright & Co., LLC ("Wainwright") acted as the placement agent in connection with the offering. Wainwright received an aggregate fee equal to 8.0% of the gross proceeds raised in the offering and warrants to purchase up to 490,000 common shares.
0
false
NLS Pharmaceutics Ltd.
/s/ Alexander Zwyer
Alexander Zwyer
Chief Executive Officer
2024-04-03